# Mechanisms of Glaucoma: IL-6, Iron Overload & BMP Pathways
> Explore the role of IL-6 signaling, iron overload, and the BMP/JAK-STAT pathways in ocular neurodegeneration and glaucoma beyond elevated IOP.

Tags: glaucoma, neurodegeneration, ophthalmology, il-6, iron-overload, biomedical-science, medical-research
## IL-6, Iron Overload & Glaucoma
- Presentation on ocular neurodegeneration pathways: BMP & JAK-STAT.
- Focus on neuro-ophthalmology research.

## Anatomy of the Eye & Retinal Layers
- **Layers:** Cornea, Sclera, Choroid, Iris, Lens, Retina, and Optic Nerve.
- **Primary Target:** Retinal Ganglion Cells (RGCs) are the cells primarily lost in glaucoma.

## Retinal Layers & Glaucoma
- Detail on the 10 retinal layers.
- Ganglion Cell Layer (GCL) undergoes apoptosis in glaucoma due to elevated IOP, oxidative stress, and neuroinflammation (IL-6, MCP-1).

## BMP Pathway — Iron Sensing & Hepcidin Regulation
- Mechanism: Iron increases trigger BMP6 release -> SMAD1/5/8 phosphorylation -> Hepcidin transcription -> Ferroportin degradation -> Decreased iron absorption.

## JAK-STAT Pathway — IL-6 Driven Inflammation
- IL-6 binds IL-6Ra receptor, recruiting gp130.
- Activates JAK1/JAK2/TYK2 and phosphorylates STAT3.
- Leads to transcription of inflammation genes and hepcidin.

## IL-6: The Master Regulator
- IL-6 plays a dual role in classic and trans-signaling.
- Independently upregulates hepcidin via STAT3 binding, bypassing the BMP/SMAD route.
- Results in iron trapping and mitochondrial dysfunction.

## Iron Overload & Hepcidin — The Ferroportin Axis
- Hepcidin binds ferroportin causing its degradation.
- Cellular iron overload leads to ROS generation and RGC death via the Fenton reaction.

## ELISA Protocol — Measuring IL-6 in Glaucoma
- Workflow for testing aqueous humor samples.
- Expected findings: IL-6 elevated in POAG patients vs. controls (p<0.05).

## MCP-1 & IP-10 in Glaucoma
- MCP-1 (CCL2) recruits monocytes/macrophages.
- IP-10 (CXCL10) recruits T-cells.
- Both amplify neuroinflammation at the optic nerve head.

## Summary & Therapeutic Implications
- **Conclusion:** IL-6/JAK-STAT inhibitors (e.g., tocilizumab) may represent a novel neuroprotective strategy to reduce iron overload and preserve vision.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.